NCT01028703

Brief Summary

Studies of patients with established kidney disease, even when this is mild, appear to show that they are at high risk of heart failure, stroke and sudden cardiac death. This may be because kidney disease causes stiffening of the arteries in the body which means that the heart and brain are damaged by high blood pressure. By studying patients before and after the removal of a kidney (uni-nephrectomy) for transplantation the investigators will find out for the first time in man the effect of an isolated reduction in kidney function on the structure and function of the arteries and heart. Hypotheses. An isolated reduction in GFR occuring after surgical uni-nephrectomy is associated with long term adverse cardiac and vascular effects which include:

  1. 1.Increased arterial stiffness and left ventricular mass
  2. 2.Abnormalities in left ventricular systolic and diastolic function
  3. 3.Increased oxidative stress, inflammation and collagen turnover

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 9, 2009

Completed
9 months until next milestone

Study Start

First participant enrolled

September 1, 2010

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

December 3, 2015

Status Verified

December 1, 2015

Enrollment Period

3.9 years

First QC Date

December 8, 2009

Last Update Submit

December 2, 2015

Conditions

Keywords

Chronic kidney diseaseleft ventricular dysfunctiondiastolic dysfunctionhypertension

Outcome Measures

Primary Outcomes (2)

  • Left ventricular mass as measured by CMR and Echocardiography

    3 years

  • Arterial stiffness as measured by pulse wave velocity

    3 years

Secondary Outcomes (3)

  • Aortic compliance measured by cardiac magnetic resonance imaging

    3 years

  • Left ventricular systolic and diastolic elastance measured by echocardiography;

    3 years

  • Oxidative stress, inflammation and collagen turnover measured by blood assays of plasma renin, aldosterone, high sensitivity C-reactive protein (hsCRP), procollagen type III aminoterminal peptide (PIIINP) and C-telopeptide for type I collagen (CITP).

    3 years

Study Arms (2)

Donors

110 will be "cases" that undergo uninephrectomy

Controls

110 "controls"

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Renal outpatient clinic

You may qualify if:

  • Potential kidney donor attending University Hospital Birmingham NHS Foundation Trust

You may not qualify if:

  • Diabetes mellitus
  • Atrial fibrillation
  • Left ventricular dysfunction (ejection fraction \<40% on transthoracic echocardiography)
  • History of cardiovascular or pulmonary disease
  • Evidence of hypertensive end-organ damage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Birmingham NHS Foundation Trust

Birmingham, West Midlands, B15 2TT, United Kingdom

Location

Related Publications (1)

  • Moody WE, Ferro CJ, Edwards NC, Chue CD, Lin EL, Taylor RJ, Cockwell P, Steeds RP, Townend JN; CRIB-Donor Study Investigators. Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors. Hypertension. 2016 Feb;67(2):368-77. doi: 10.1161/HYPERTENSIONAHA.115.06608.

MeSH Terms

Conditions

Renal Insufficiency, ChronicVentricular Dysfunction, LeftHypertension

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsVentricular DysfunctionHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Jonathan N Townend

    Univeristy Hospital Birmingham NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
BHF Clinical Research Fellow

Study Record Dates

First Submitted

December 8, 2009

First Posted

December 9, 2009

Study Start

September 1, 2010

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

December 3, 2015

Record last verified: 2015-12

Locations